Launch of the UK Chemotherapy Board Website

The Board was established in 2013 by The Royal College of Radiologists (RCR), the Royal College of Physicians (RCP), the Association of Cancer Physicians (ACP), the Royal College of Pathologists (RCPath), the British Oncology Pharmacy Association (BOPA) and the UK Oncology Nursing Society (UKONS). The Royal College of Paediatrics and Child Health (RCPCH) is also a member and UKCB has representation from across the four UK nations and from other organisations actively involved in chemotherapy services. The board’s strategic roles include:

  • working collaboratively with other groups and organisations across the UK involved in the delivery of chemotherapy services, including the chemotherapy clinical reference group and the joint collegiate council for oncology
  • advising on the development and delivery of safe, high-quality chemotherapy services
  • coordinating work at national level to support commissioning and delivery of services locally

In the future the UK Chemotherapy Board is looking to contribute stakeholder views to the NHS chemotherapy clinical reference group (CRG) in its development of commissioning policies. In addition, it is currently developing a strategy and structure for workforce planning and training as well as continuing to build and disseminate professional guidance and standards for chemotherapy service delivery. In the future data sources will be vital in evaluating chemotherapy service provision and the UKCB will support and encourage the development of these sources. It will also work collaboratively to support and encouraging research in chemotherapy. 

The new website is a central place for all publications, position statements and guidance that have been published since its establishment in 2013. You will also be able to find current members and past minutes as well as other useful information about the board in this single location. These include a range of current policies and guidelines, good practice guidelines and a section on managing SACT during the COVID-19 pandemic.